Fetal liver transplantation: Biology and clinical results

J. L. Touraine; M. G. Roncarolo; R. Bacchetta; D. Raudrant; A. Rebaud; S. Laplace; P. Cesbron; L. Gebuhrer; M. T. Zabot; F. Touraine; D. Frappaz; G. Souillet; C. Vullo

Fetal liver transplantation: Biology and clinical results

J. L. Touraine, M. G. Roncarolo, R. Bacchetta, D. Raudrant, A. Rebaud, S. Laplace, P. Cesbron, L. Gebuhrer, M. T. Zabot, F. Touraine, D. Frappaz, G. Souillet, C. Vullo

IRCCS Ospedale San Raffaele

Research output: Contribution to journal › Article › peer-review

Abstract

Over the last 18 years, we have developed the transplantation of fetal liver cells to treat severe immunodeficiencies, hematological disorders and inborn errors of metabolism. Post-natally, this treatment is successful in two-third of patients and it is therefore very valuable, especially when there is no perfectly matched donor for a bone marrow transplant. Since 1988 we have carried out these fetal liver transplants (FLTs) in utero, immediately after prenatal diagnosis. Engraftment and reconstitution have been obtained, and several advantages appear to be associated with in utero FLT: increased probability of graft take, ideal isolation of the patient (in the maternal uterus) and optimal environment for the differentiation of the transplanted fetal liver cells (in the fetal host).

Original language	English
Pages (from-to)	119-122
Number of pages	4
Journal	Bone Marrow Transplantation
Volume	11
Issue number	SUPPL. 1
Publication status	Published - 1993

ASJC Scopus subject areas

Hematology
Transplantation

Cite this

Fetal liver transplantation : Biology and clinical results. / Touraine, J. L.; Roncarolo, M. G.; Bacchetta, R.; Raudrant, D.; Rebaud, A.; Laplace, S.; Cesbron, P.; Gebuhrer, L.; Zabot, M. T.; Touraine, F.; Frappaz, D.; Souillet, G.; Vullo, C.

In: Bone Marrow Transplantation, Vol. 11, No. SUPPL. 1, 1993, p. 119-122.

Research output: Contribution to journal › Article › peer-review

@article{09a9bf8b2409412c8ddcd6a49c7286ac,

title = "Fetal liver transplantation: Biology and clinical results",

abstract = "Over the last 18 years, we have developed the transplantation of fetal liver cells to treat severe immunodeficiencies, hematological disorders and inborn errors of metabolism. Post-natally, this treatment is successful in two-third of patients and it is therefore very valuable, especially when there is no perfectly matched donor for a bone marrow transplant. Since 1988 we have carried out these fetal liver transplants (FLTs) in utero, immediately after prenatal diagnosis. Engraftment and reconstitution have been obtained, and several advantages appear to be associated with in utero FLT: increased probability of graft take, ideal isolation of the patient (in the maternal uterus) and optimal environment for the differentiation of the transplanted fetal liver cells (in the fetal host).",

author = "Touraine, {J. L.} and Roncarolo, {M. G.} and R. Bacchetta and D. Raudrant and A. Rebaud and S. Laplace and P. Cesbron and L. Gebuhrer and Zabot, {M. T.} and F. Touraine and D. Frappaz and G. Souillet and C. Vullo",

year = "1993",

language = "English",

volume = "11",

pages = "119--122",

journal = "Bone Marrow Transplantation",

issn = "0268-3369",

publisher = "Nature Publishing Group",

number = "SUPPL. 1",

}

TY - JOUR

T1 - Fetal liver transplantation

T2 - Biology and clinical results

AU - Touraine, J. L.

AU - Roncarolo, M. G.

AU - Bacchetta, R.

AU - Raudrant, D.

AU - Rebaud, A.

AU - Laplace, S.

AU - Cesbron, P.

AU - Gebuhrer, L.

AU - Zabot, M. T.

AU - Touraine, F.

AU - Frappaz, D.

AU - Souillet, G.

AU - Vullo, C.

PY - 1993

Y1 - 1993

N2 - Over the last 18 years, we have developed the transplantation of fetal liver cells to treat severe immunodeficiencies, hematological disorders and inborn errors of metabolism. Post-natally, this treatment is successful in two-third of patients and it is therefore very valuable, especially when there is no perfectly matched donor for a bone marrow transplant. Since 1988 we have carried out these fetal liver transplants (FLTs) in utero, immediately after prenatal diagnosis. Engraftment and reconstitution have been obtained, and several advantages appear to be associated with in utero FLT: increased probability of graft take, ideal isolation of the patient (in the maternal uterus) and optimal environment for the differentiation of the transplanted fetal liver cells (in the fetal host).

AB - Over the last 18 years, we have developed the transplantation of fetal liver cells to treat severe immunodeficiencies, hematological disorders and inborn errors of metabolism. Post-natally, this treatment is successful in two-third of patients and it is therefore very valuable, especially when there is no perfectly matched donor for a bone marrow transplant. Since 1988 we have carried out these fetal liver transplants (FLTs) in utero, immediately after prenatal diagnosis. Engraftment and reconstitution have been obtained, and several advantages appear to be associated with in utero FLT: increased probability of graft take, ideal isolation of the patient (in the maternal uterus) and optimal environment for the differentiation of the transplanted fetal liver cells (in the fetal host).

UR - http://www.scopus.com/inward/record.url?scp=0027460465&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027460465&partnerID=8YFLogxK

M3 - Article

C2 - 8448534

AN - SCOPUS:0027460465

VL - 11

SP - 119

EP - 122

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - SUPPL. 1

ER -

Fetal liver transplantation: Biology and clinical results

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this